Phenotypes of idiopathic pulmonary arterial hypertension
- PMID: 36179741
- DOI: 10.1016/S2213-2600(22)00304-6
Phenotypes of idiopathic pulmonary arterial hypertension
Conflict of interest statement
KE-K provided consultative services to Acceleron, served on advisory boards for J&J, Actelion, and United Therapeutics, received institutional research funding from J&J Actelion and United Therapeutics, and participated in a United Therapeutics speaker's bureau (2018–21). SDN is a consultant for United Therapeutics, Bellerophon, Roche, Merck, Third Pole, Pliant, and Daewoong. He is on the speaker's bureau for United Therapeutics and Boehringer-Ingelheim. Both authors contributed equally to this manuscript and approved the final version.
Comment in
-
Phenotypes of idiopathic pulmonary arterial hypertension - Authors' reply.Lancet Respir Med. 2022 Oct;10(10):e90-e91. doi: 10.1016/S2213-2600(22)00273-9. Lancet Respir Med. 2022. PMID: 36179743 No abstract available.
Comment on
-
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.Lancet Respir Med. 2022 Oct;10(10):937-948. doi: 10.1016/S2213-2600(22)00097-2. Epub 2022 Jun 28. Lancet Respir Med. 2022. PMID: 35777416 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
